# PubMed record PMID 29260289

> PeptideScanner retained PubMed bibliographic metadata for PMID 29260289 at 2026-07-30T20:57:06.138Z. PubMed recorded a metadata revision date of 2019-02-25 and an Entrez history date of 2017-12-21. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date.

- Evidence object: `story:pubmed-pmid-29260289-abaloparatide:v1`
- Evidence domain: Literature metadata
- Date in source: 2019-02-25
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-12
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-29260289-abaloparatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-29260289-abaloparatide-v1.json
- Content SHA-256: `ec5e51aaf1a302068da880366266e23dbb746cb3864f2de7ec3a5c5c446ad042`

## Claims and source pins

### Headline

PubMed record PMID 29260289 ([`pubmed-observation-pmid-29260289-2019-02-25-e15f996dfaa7`](#source-pubmed-observation-pmid-29260289-2019-02-25-e15f996dfaa7))

### Summary

PeptideScanner retained PubMed bibliographic metadata for PMID 29260289 at 2026-07-30T20:57:06.138Z. PubMed recorded a metadata revision date of 2019-02-25 and an Entrez history date of 2017-12-21. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-29260289-2019-02-25-e15f996dfaa7`](#source-pubmed-observation-pmid-29260289-2019-02-25-e15f996dfaa7))

### Paragraph 1

PeptideScanner retained PubMed bibliographic metadata for PMID 29260289 at 2026-07-30T20:57:06.138Z. PubMed recorded a metadata revision date of 2019-02-25 and an Entrez history date of 2017-12-21. PeptideScanner associated this retained record with the identity slug abaloparatide. These dates describe PubMed metadata history, not the article's original publication date. ([`pubmed-observation-pmid-29260289-2019-02-25-e15f996dfaa7`](#source-pubmed-observation-pmid-29260289-2019-02-25-e15f996dfaa7))

### Paragraph 2

This page reports retained PubMed bibliographic metadata. It does not summarize the article, establish the article's publication date, or assert safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-29260289-2019-02-25-e15f996dfaa7`](#source-pubmed-observation-pmid-29260289-2019-02-25-e15f996dfaa7))

## Sources

<a id="source-pubmed-observation-pmid-29260289-2019-02-25-e15f996dfaa7"></a>
- **PubMed record PMID 29260289 · retained source version 1:2019-02-25:current:e15f996dfaa70bec31f7538732a4aa708d62ae47b1bd1082a2264ae0b547eff8** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/29260289/) (`pubmed-observation-pmid-29260289-2019-02-25-e15f996dfaa7`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "PubMed record PMID 29260289." Version 1, published 2026-08-12. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-29260289-abaloparatide-v1.json SHA-256: ec5e51aaf1a302068da880366266e23dbb746cb3864f2de7ec3a5c5c446ad042.